Linear Type Azo-containing Polyurethanes for Colon-specific Drug Delivery

Journal of Bioactive and Compatible Polymers

Volumn 19, Issue 1, 2004, Pages 45-53

  Mahkam, M ^a   Assadi, M G ^a   Zahedifar, R ^a   Ramesh, M ^a   Davaran, S ^b  

^a AZARBAIJAN SHAHID MADANI UNIVERSITY   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

5 aminosalicylic acid; Biodegradable; Hydrolysis; pH sensitive; Polymeric prodrug

Indexed keywords

BIODEGRADATION; DIALYSIS; HYDROLYSIS; ORGANIC ACIDS; PH EFFECTS; POLYURETHANES; SPECTROSCOPY;

COLON-SPECIFIC DRUG DELIVERY; URETHANE BONDS;

DRUG PRODUCTS;

5 [4 (HYDROXYLPHENYL)AZO]SALICYLIC ACID; AZO COMPOUND; HEXAMETHYLENE DIISOCYANATE; MESALAZINE; OLSALAZINE; POLYURETHAN; PRODRUG; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; BIODEGRADABILITY; CHEMICAL BOND; COLON; DIALYSIS; DRUG DELIVERY SYSTEM; HYDROLYSIS; INFRARED SPECTROSCOPY; PROTON NUCLEAR MAGNETIC RESONANCE; ULTRAVIOLET SPECTROSCOPY;

EID: 1642359153     PISSN: 08839115     EISSN: None     Source Type: Journal    
DOI: 10.1177/0883911504041602     Document Type: Article

References (30)

1. Dew, M.J., Hughes, P.J., Lee, M.G., Evans, B.K. and Rhodes, J. (1982). An Oral Preparation to Release Drug in Human Colon, Br. J. Clin. Pharmacol., 14: 405-408.
2. Schroder, K.W. and Termaine, W.J. (1987). Coated Oral 5-Aminosalicylic Acid Therapies for Mildly to Moderately Active Ulcerative Colitis, N. Engl. J. Med., 317: 1625-1629.
3. Schroder, H. and Johansson, A.K. (1973). Redox Potential in Caecal Contents of the Rat and Azo Reduction of Salicylazosulphapyridene, Xenobiotics, 3: 233-246.
4. Miyadera, T. (1975). Biological Formation and Reaction of Hydrazo, Azo and Azoxy Groups, In: Patai, S. (ed.), The Chemistry of Hydrozo, Azo and Azoxy Compounds, p. 495, Part 1, Wiley, New York.
5. Walker, R. (1970). Metabolism of Azo Group: A Review of Literature, Food Cosmet. Toxicol., 8: 659-676.
6. Radomski, J.L. and Mellinger, T.J. (1962). Absorption, Fate and Excretion in Rats of Soluble Azo Dyes, J. Pharmacol. Exp. Ther., 136: 259.
7. Dieckhues, B. (1960). Reductive Splitting of Azo Dyes by Bacteria, Zentralbl. Bakteriol. Parasitenkd., 180: 244.
8. Fuller, A.T. (1937). Is p-Amino Benzene Sulfonamide the Active Agent in Protosil Therapy, Lancet, 1: 194.
9. Daniel, J.W. (1962). The Excretions and Metabolism of Edible Food Colors, Toxicol. Appl. Pharmacol., 4: 572.
10. Scheline, R.R. and Longberg, B. (1965). The Absorption, Metabolism and Excretion of Sulfonated Azo Dye, Acid Yellow, by Rats, Acta Pharmacol. Toxicol., 23: 1.
11. Schroeder, H. and Campbell, D.E. (1972). Absorption, Metabolism and Excretion of Salicylazosulfopyridine in Man, Clin. Pharmacol. Ther., 13: 539.
12. Dubru, D. and Wright, K.L. (1975). Reduction of Azo Food Dyes in Cultures of Proteus Vulgaris, Xenobiotics, 5: 563.
13. Hanohan, T.E., Enderlin, B.A. and Parkinson, T.M. (1977). Intestinal Absorption of Polymeric Derivatives of the Food Dyes Sunset Yellow and Tartriazine in Rats, Xenobiotics, 7: 765.
14. Brown, J.P. (1981). Reduction of Polymeric Azo and Nitro Dyes by Intestinal Bacteria, Appl. Environ. Microbiol., 41: 1283.
15. Chung, K.T., Flunk, G.E. and Egan, M. (1976). Azo Dye Reduction by Anaerobes, Appl. Environ. Microbiol., 5: 558.
16. Askelof, E.E., Svart, N. and Willstaedt, H.C. (1946). Heterocyclic Sulfon Amido Azo Compounds, US Patent 2396, 145.
17. Kisner, J.B. (1980). Observation on the Medical Treatment of Inflammatory Bowel Disease, J. Am. Med. Assoc., 243: 557-564.
18. Klotz, U., Maier, K., Fisher, C. and Heinkal, K. (1980). Therapeutic Efficiency of Sulfasalazine and its Metabolites in Patients with Ulcerative Colitis and Crohns Disease, N. Engl. J. Med., 303: 1499-1502.
19. Parkinson, T.M., Brown, J.P. and Wingard, R.E. (1980). US Patent 4.196, 176, February 20.
20. Parkinson, T.M., Brown, J.P. and Wingard, R.E. (1981). US Patent 4.298, 595, November 3.
21. Brown, J.P., McCarraugh, G.V., Parkinson, T.M., Wingard Jr, R.E. and Onderdonk, A.B. (1983). Polymeric Drug for Treatment of Inflammatory Bowel Disease, A. J. Med. Chem. 26: 1300-1307.
22. Callant, D. and Schacht, E. (1990). Macromolecular Prodrugs of 5-Aminosalicylic Acids, 1. Azoconjugates, Makromol. Chem., 191: 529-536.
23. Kopeckova, P. and Kopecek, J. (1990). Release of 5-AminosalicyUc Acids from Bioadhesive N-(2-Hydroxypropyl) Methaacrylamide Copolymers by Azoreductese In-Vitro, Makromol. Chem., 191: 2037-2045.
24. Van, G., Offringa, M., Kalaia, W., Samyn, C. and Kinget, R. (1995). Synthesis and Evaluation of New Linear Azo-polymers for Colonic Targeting, S. T. P. Pharma Sciences, 5: 36-40.
25. Selby, W.S., Barr, G.D. and Ireland, A. et al. (1985). Olsalazine in Active Ulcerative Colitis, BMJ, 291: 1373-1375.
26. Sandberg-Gerzen, H., Jarnerot, G. and Kraaz, W. (1986). Azodisal Sodium in the Treatment of Ulcerative Colitis, Gastroenterology; 90: 1024-1030.
27. Stinson, S. (1994). Polymer Used to Block Blood-supply to Tumours, C&EN, 72(50): 40.
28. Mahkam, M. and Sharifi, N. (2003). Preparation of New Biodegradable Polyurethanes as a Therapeutic Agent, Polymer Degradation and Stability, 80: 199-202.
29. Yamaoka, T., Makita, Y., Sasatani, H., Kim, S. and Kimura, Y. (2000). Linear Type Azo-containing Polyurethane as Drug-coating Material for Colon-specific Delivery, J. Control. Release, 66: 187-197.
30. Kuzuya, M. and Kondo, S. (1991). Chem. Pharm. Bull., 39(11): 3018-3022.